Ashina M, et al. Impact of fremanezumab on headache-related disability in patients with migraine and documented inadequate response to 2–4 classes of migraine preventive medications in the multicentre, randomised, placebo-controlled FOCUS study. IHC-PO-154. IHC 2019 5-8 sept. Dublin, Ierland.
Biobank ideale bron voor onderzoek naar COVID-19
sep 2020 | Dementie, Multipele Sclerose, Neuro-musculair